Trials / Recruiting
RecruitingNCT05815199
E-cigarettes for Harm Reduction Among Smokers With Serious Mental Illness
Effectiveness and Impact of Counseling Enhanced Using Electronic Cigarettes for Harm Reduction in People With Serious Mental Illness
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- NYU Langone Health · Academic / Other
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
In this open-label, randomized controlled trial study, participants who smoke combustible cigarettes (CC) and are diagnosed with Serious Mental Illness (SMI) will be randomized in two arms to receive harm-reduction counseling and Ecological Momentary Intervention text messaging (EMI) along with either e-cigarettes (EC) or nicotine replacement therapy (NRT) such as patch and lozenges to compare the efficacy in CC smoking reduction.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | E-cigarette (EC) | Fixed dose. Participants are to use the EC as replacement for smoking combustible cigarettes. Participants will vape the EC. |
| OTHER | Nicotine Replacement Therapy (NRT) | Includes nicotine patches and lozenges. NRT use recommendations will follow the guidelines of the product, e.g. one patch per day. |
| BEHAVIORAL | Harm-Reduction Counseling | At baseline, after randomization, participants will receive their first telehealth session (20\~25 minutes) from a counselor trained in motivational interviewing, harm reduction, and smoking cessation. Up to five additional sessions will be delivered, 15\~20 minutes each. |
| BEHAVIORAL | Ecological Momentary Intervention (EMI) Text Messaging | EMI can be defined as delivering tailored interventions via electronic messages (i.e., regular text messages) that include personalized feedback based on real-time assessment responses and other contextual factors. EMI will take place throughout the intervention period. |
Timeline
- Start date
- 2023-11-13
- Primary completion
- 2026-03-01
- Completion
- 2026-03-01
- First posted
- 2023-04-18
- Last updated
- 2025-10-10
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05815199. Inclusion in this directory is not an endorsement.